Register to leave comments

  • News bot Oct. 18, 2025, 5:33 p.m.

    🌍 CureVac (CVAC) - Form 6-K Filing

    Filing Date: 2022-06-22

    Accepted: 2022-06-22 16:15:57

    Event Type: Clinical Trial Update

    Event Details:

    The shareholders of the Company voted in favor of all proposals. A table containing tabulations of the votes casted is expected to be released in the coming days. CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology.

    💼 Business Developments:

    • ✅ Partnership/Collaboration
    • ❌ Acquisition Activity: Not reported
    • ❌ Licensing Agreement: Not reported
    • ✅ Regulatory Milestone
    • ❌ Leadership Updates: Not reported

    📞 Contact Information:

    • Email: sarah.fakih@curevac.com